IL-33 Signaling in Lung Injury
Translational Perioperative and Pain Medicine · 2016
DOI: 10.31480/2330-4871/037 ↗Kurz gefasst
Fachartikel in der Zeitschrift Translational Perioperative and Pain Medicine, 2016. Verfasst von Chang Jing und 3 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
Interleukin (IL)-33, a member of the IL-1 cytokine super-family, acts as both a traditional cytokine and an intracellular nuclear factor. It is generally released from damaged immune cells and signals through its receptor ST2 in an autocrine and paracrine fashion, plays important roles in type-2 innate immunity, and functions as an "alarmin" or a danger signal for cellular damage or cellular stress. Here, we review recent advances of the role of IL-33 in lung injury and explore its potential significance as an attractive therapeutic target.
Zitieren
APA
Jing, C., Yue-Feng, X., Ma-Zhong, Z., & Li-Ming, Z. (2016). IL-33 Signaling in Lung Injury. Translational Perioperative and Pain Medicine. https://doi.org/10.31480/2330-4871/037
Vancouver
Jing C, Yue-Feng X, Ma-Zhong Z, Li-Ming Z. IL-33 Signaling in Lung Injury. Translational Perioperative and Pain Medicine. 2016. doi:10.31480/2330-4871/037
BibTeX
@article{Jing2016,
author = {Jing, Chang and Yue-Feng, Xia and Ma-Zhong, Zhang and Li-Ming, Zhang},
title = {IL-33 Signaling in Lung Injury},
journal = {Translational Perioperative and Pain Medicine},
year = {2016},
doi = {10.31480/2330-4871/037}
}
EUVIMED